Potential E2A binding sites are also present within the alternate promoter and these alternative NOTCH1 isoforms are expressed in E2a-/- leukemias indicating that E proteins may cooperate with IKAROS to repress alternative promoter use (104). Here, NOTCH1 is linked to leukemia.